Emerging Global Therapies in Clinical Trials in Progress for Endometrial and Ovarian Cancers, Understanding the Landscape and Optimizing Strategies
Activity Overview
The GOG Foundation, Inc. and GOG Partners welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to register for the Emerging Global Therapies in Clinical Trials in Progress for Endometrial and Ovarian Cancers, Understanding the Landscape and Optimizing Strategies Industry Supported Symposium at the IGCS 2024 Annual Global Meeting in Dublin, Ireland.
This comprehensive course provides an in-depth exploration of clinical trials in progress for ovarian and endometrial cancers, offering valuable insights into ongoing research opportunities and competitive dynamics shaping the field. Participants will delve into key components of clinical trials, including study design, sequencing of trials, and learning about new opportunities for patients, gaining a solid understanding of the fundamentals essential for navigating research endeavors in these malignancies. Through dynamic discussions, participants will explore the ever-evolving competitive landscape of clinical trials in ovarian and endometrial cancers. Analyzing emerging therapies, novel treatment modalities, and investigational agents, attendees will gain insights into current trends and advancements influencing research directions and treatment paradigms. Join us for an enlightening journey through the intricacies of clinical trials in ovarian and endometrial cancers and equip yourself with the knowledge and skills to navigate the ever-evolving landscape of oncology research with confidence and expertise.
The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education associated with this Symposium: Gilead, Karyopharm Therapeutics, Genmab, ImmunoGen (now part of AbbVie), Corcept Therapeutics, and Sutro Biopharma.
Target Audience
The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.
Learning Objectives
Upon completion of the activities in this series, learners will demonstrate Increased knowledge regarding:
- Analyze the key components of clinical trials in progress, including study design, participant recruitment, and data collection methods, to understand the fundamentals of ongoing research opportunities in ovarian and endometrial cancers.
- Explore the dynamic competitive landscape of clinical trials in ovarian and endometrial cancers, analyzing emerging therapies, novel treatment modalities, and investigational agents to understand current trends and advancements shaping the field.
- Assess and apply knowledge of the impact of the competitive trials landscape to optimize trial planning, execution, and enhance trial feasibility and success.
- Understand the global reach of clinical trials in progress.
Moderator
Dr. Bradley Monk
Faculty
Dr. Nicoletta Columbo
Dr. Graziela Dal Molin
Dr. Keiichi Fujiwara
Dr. Jae Hoon Kim
Dr. Stephanie Lheureux
Agenda
Emerging Global Therapies in Clinical Trials in Progress for Endometrial and Ovarian Cancers, Understanding The Landscape and Optimizing Strategies, an Industry Supported Symposium at the IGCS 2024 Annual Global Meeting
In Person on Friday, October 18, 2024 from 12:45 – 14:15 IST/GMT+1
This session is not included in the main event CME/CPD credit.